Evaluated in this study were the feasibility and the efficacy of concurrent low dose fractionated radiotherapy (LD-FRT) and chemotherapy as palliative treatment for recurrent/progressive glioblastoma multiforme (GBM).
Balducci, M., Diletto, B., Chiesa, S., D'Agostino, G. R., Gambacorta, M. A., Ferro, M., Colosimo, C., Maira, G., Anile, C., Valentini, V., Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study, <<STRAHLENTHERAPIE UND ONKOLOGIE>>, 2014; 190 (4): 370-376. [doi:10.1007/s00066-013-0506-z] [http://hdl.handle.net/10807/63824]
Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study
Balducci, Mario;Diletto, Barbara;Chiesa, Silvia;D'Agostino, Giuseppe Roberto;Gambacorta, Maria Antonietta;Ferro, Marica;Colosimo, Cesare;Maira, Giulio;Anile, Carmelo;Valentini, Vincenzo
2014
Abstract
Evaluated in this study were the feasibility and the efficacy of concurrent low dose fractionated radiotherapy (LD-FRT) and chemotherapy as palliative treatment for recurrent/progressive glioblastoma multiforme (GBM).
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
